CSF3 and type 1 diabetes mellitus: ATG, cyclophosphamide, and G-CSF were key components of autologous non-myeloablative hematopoietic stem cell transplants, which restored insulin independence in patients with T1D but conferred high risk of morbidity (e.g., severe neutropenia requiring extended hospitalization, gonadal dysfunction, alopecia) [251, 252].